{"title":"Biden administration expects J&J boosters in the next few weeks","link":"https://arstechnica.com/?p=1800912","date":1633389627000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269-800x522.jpeg\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/04/GettyImages-1232239269.jpeg\">Enlarge</a> <span>/</span> Boxes of Johnson &amp; Johnson's Janssen COVID-19 vaccine at a vaccination site in Florida. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/johnson-johnson-covid-19-vaccine-boxes-are-seen-at-a-news-photo/1232239269?adppopup=true\">Getty | Paul Hennessy</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>Johnson &amp; Johnson plans to seek authorization for a booster dose for its one-shot COVID-19 vaccine early this week, according to <a href=\"https://www.nytimes.com/2021/10/04/us/politics/johnson-vaccine-booster-coronavirus.html?action=click&amp;module=RelatedLinks&amp;pgtype=Article\">a report by The New York Times</a>.</p>\n<p>J&amp;J is the last to apply for booster authorization among the makers of the three COVID-19 vaccines used in the US. Yet, it is the booster that many health officials are most eager to see. The vaccine, which uses a viral vector strategy rather than an mRNA-based design, is the only available COVID-19 vaccine given as just one shot. Its efficacy has lagged behind the other vaccines throughout the pandemic.</p>\n<p>Still, Moderna and Pfizer-BioNTech, both mRNA-based vaccine, have already submitted booster applications to US regulators. On September 22, the Food and Drug Administration <a href=\"https://arstechnica.com/science/2021/09/following-expert-advice-fda-authorizes-boosters-for-people-65-high-risk/\">granted authorization for a booster dose</a> of the Pfizer-BioNTech vaccine for certain groups of people. The decision was tense, with experts torn over whether a booster for the highly effective vaccine was widely needed.</p></div><p><a href=\"https://arstechnica.com/?p=1800912#p3\">Read 6 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1800912&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"baff1749c668ae1e367772ba807cd618c29e0ec49e96a4321479fe7d35febda6","category":"Tech"}